Cannabis Law Report

DECEMBER 9, 2021

(the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed the manufacturing of its clinical grade supply (“cGMP”) of AP-188 (“ N , N -Dimethyltryptamine or DMT”) at Canadian manufacturer Dalton Pharma Services.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Let’s explore this in more detail. What exactly is ALS?

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

JUNE 10, 2021

In short the study learns that legalized states tend not to have their roads overcrowded with stoned drivers and cannabis users like alcohol users self police their behaviour. The prevalence of cannabis-involved driving in California. Cannabis effects on driving skills. J Anal Toxicol. 2014;38(8):569–74. Drug Alcohol Depend.

Policy 59

Policy Safety Marijuana Data 59

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

NOVEMBER 24, 2021

Medical publications, are, in the main fairly positive toward cannabis. Published by The Journal of Cannabis Research. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. At the same time, the outlook on cannabis research data is largely positive. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Green Relief

MAY 13, 2018

The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. government still maintains that cannabis is a dangerous drug with no medical value. How does cannabis, and THC , in particular, confer neuroprotective effects? But the U.S.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. government still maintains that cannabis is a dangerous drug with no medical value. How does cannabis, and THC , in particular, confer neuroprotective effects? But the U.S.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40